Patent details
EP2207562 Title: ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR DECREASING OR INHIBITING FSH SECRETION
Basic Information
- Publication number:
- EP2207562
- PCT Application Number:
- US2008010868
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP088322599
- PCT Publication Number:
- WO2009038745
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR DECREASING OR INHIBITING FSH SECRETION
- French Title of Invention:
- ANTAGONISTES DE L'ACTIVINE-ACTRIIA ET UTILISATIONS POUR RÉDUIRE OU EMPÊCHER LA SÉCRÉTION DE FSH
- German Title of Invention:
- ACTIVIN-ACTRIIA ANTAGONISTEN UND VERFAHREN ZUR VERRINGERUNG ODER INHIBIERUNG DER FSH-SEKRETION
- SPC Number:
Dates
- Filing date:
- 17/09/2008
- Grant date:
- 31/05/2017
- EP Publication Date:
- 21/07/2010
- PCT Publication Date:
- 26/03/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 31/05/2017
- EP B1 Publication Date:
- 31/05/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/09/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2017
- Name:
- Acceleron Pharma, Inc.
- Address:
- 128 Sidney Street, Cambridge, MA 02139, United States (US)
Agent
- Name:
- Office FREYLINGER S.A.
- From:
- 07/06/2017
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KNOPF, John
- Address:
- United States (US)
2
- Name:
- SHERMAN, Matthew, L.
- Address:
- United States (US)
3
- Name:
- SEEHRA, Jasbir
- Address:
- United States (US)
Priority
- Priority Number:
- 994399 P
- Priority Date:
- 18/09/2007
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/17; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 201722
- Publication date:
- 31/05/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 11/08/2025
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 13/06/2017 | Outgoing Correspondence | 1 |
| 07/06/2017 | Power Of Attorney | 1 |